A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab

The Journal of Dermatological Treatment
N Scheinfeld

Abstract

For more than 5 years, infliximab and etanercept have been utilized to treat rheumatoid arthritis and Crohn's disease. There is therefore much post-approval data on their side effects. A variety of Medline searches were done at the beginning of June 2004 using the terms 'etanercept', 'infliximab' and 'adalimumab' and the words 'lymphoma', 'infection', 'congestive heart failure', 'demyelinating disease', 'lupus', 'antibodies', 'injection site reaction', 'systemic', 'side effects' and 'skin'. Approximately 150 articles were so identified. In addition, FDA and manufacturers' data obtained by internet searches using Google were reviewed. The important side effects that have been most extensively related to TNFalpha blockers include: lymphoma, infections, congestive heart failure, demyelinating disease, a lupus-like syndrome, induction of auto-antibodies, injection site reactions, and systemic side effects. The risk of these side effects is very low. Nevertheless, it is important for clinicians to be aware of these side effects when prescribing therapy.

Associated Clinical Trials

References

Oct 16, 1999·Annals of Internal Medicine·P H BrionK C Kalunian
Apr 18, 2000·Archives of Dermatology·F T MurphyK David-Bajar
Nov 30, 2000·The American Journal of Gastroenterology·J K TriantafillidisE Karra
Jan 11, 2001·The American Journal of Gastroenterology·R J FarrellM A Peppercorn
Jan 13, 2001·Mayo Clinic Proceedings·V V Menghini, A S Arora
Jul 27, 2001·Alimentary Pharmacology & Therapeutics·G P Aithal, J C Mansfield
Oct 13, 2001·The New England Journal of Medicine·J KeaneM M Braun
Nov 16, 2001·Rheumatology·G S BleuminkB H Stricker
Nov 27, 2001·Inflammatory Bowel Diseases·M A Ritz, R Jost
Nov 28, 2001·Neurology·N L Sicotte, R R Voskuhl
Dec 6, 2001·Lancet·H MarotteP Miossec
Jan 16, 2002·Annals of Internal Medicine·Davey Smith, Scott Letendre
Jan 17, 2002·Rheumatology·M E McCainW E Davis
Jan 18, 2002·Postgraduate Medical Journal·A T Y ChanT J Daymond
Jan 29, 2002·The American Journal of Medicine·Masha Nakelchik, Julie E Mangino
Mar 21, 2002·The British Journal of Dermatology·L MiseryC Alexandre
Apr 17, 2002·Lancet·A S Kashyap, Surekha Kashyap
May 15, 2002·Annals of the Rheumatic Diseases·E AndrésJ Sibilia
Jun 18, 2002·Digestive Diseases and Sciences·Maeve O'ConnorGailen Marshall
Jun 25, 2002·Annals of the Rheumatic Diseases·D C Baumgart, A U Dignass
Jul 26, 2002·American Journal of Ophthalmology·Claus CursiefenLeonard M Holbach
Aug 15, 2002·Annals of the Rheumatic Diseases·F SoliotisA S M Jawad
Sep 5, 2002·Arthritis and Rheumatism·Peter D KentEric L Matteson
Sep 13, 2002·Archives of Dermatology·Gloria VergaraJosé Carlos Pascual
Oct 9, 2002·Congestive Heart Failure·Kevin A LismanGuillermo Torre-Amione
Oct 16, 2002·Annals of the Rheumatic Diseases·A P CairnsA J Taggart
Nov 12, 2002·Chest·Laura Peno-GreenSteven Brantley
Dec 7, 2002·European Journal of Gastroenterology & Hepatology·Daniel HelblingMartin Krause
Jan 25, 2003·Journal of Clinical Gastroenterology·Efrat Z LobelJonathan I Warman
Feb 28, 2003·Clinical Rheumatology·M DebandtO Meyer
Mar 14, 2003·Annals of the Rheumatic Diseases·C T Derk, R J DeHoratius

❮ Previous
Next ❯

Citations

Jul 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Melissa K McCoyMalú G Tansey
Nov 29, 2011·Annals of the Rheumatic Diseases·Yoshiya TanakaUNKNOWN GO-FORTH Study Group
Feb 18, 2012·International Archives of Medicine·Eduardo Puertas-AbreuUNKNOWN GRUPO GRUVES: grupo Venezolano para el Estudio de las Espondiloartritis
Dec 19, 2013·Mediators of Inflammation·Angela JiangJohn Byron Christoforidis
Feb 20, 2016·International Journal of Pharmaceutics·Vipul YadavAbdul W Basit
Jul 14, 2005·Expert Opinion on Drug Safety·Noah Scheinfeld
Jan 22, 2013·Expert Opinion on Drug Safety·Giuseppe MurdacaFrancesco Puppo
Nov 28, 2013·Expert Opinion on Emerging Drugs·Theresa G Leung, Jennifer E Thorne
Sep 29, 2005·Expert Opinion on Biological Therapy·Jean-Luc Teillaud
Dec 17, 2014·Journal of Neuroinflammation·Bettina Hjelm ClausenKate Lykke Lambertsen
Jan 27, 2016·Human Vaccines & Immunotherapeutics·Janina E Linnik, Adrian Egli
Feb 5, 2008·Mayo Clinic Proceedings·Sotirios TsiodrasDimitrios P Kontoyiannis
Nov 29, 2011·Survey of Ophthalmology·Khayyam DurraniC Stephen Foster
May 1, 2010·Seminars in Cutaneous Medicine and Surgery·Danielle Levine, Bruce E Strober
Dec 1, 2009·The Medical Clinics of North America·Meenakshi Bewtra, James D Lewis
Jan 20, 2010·Clinics in Dermatology·Carlos FerrándizAram Boada
Nov 17, 2009·Gastroenterology Clinics of North America·Meenakshi Bewtra, James D Lewis
Oct 20, 2009·Revue de stomatologie et de chirurgie maxillo-faciale·A RousseauN Zwetyenga
Apr 7, 2009·Journal of the American Academy of Dermatology·Rita V PatelJeffrey M Weinberg
Mar 2, 2006·Clinical Lymphoma & Myeloma·Cindy BerthelotMadeleine Duvic
Jun 3, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Jeffery A Engelhardt
Jun 13, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mohammed F ShamjiLori A Setton
Jun 14, 2008·Journal of the American Academy of Dermatology·Arni K KristjanssonKevin D Cooper
Jan 2, 2008·Seminars in Arthritis and Rheumatism·John C Davis, Philip J Mease
May 1, 2007·Experimental Cell Research·Nicolas LarmonierBernard Bonnotte
Aug 30, 2005·Annals of the New York Academy of Sciences·Simon Skurkovich, Boris Skurkovich
Aug 27, 2005·The British Journal of Dermatology·M R Kaur, H M Lewis
Jul 21, 2005·The British Journal of Dermatology·S DalleL Thomas
Dec 17, 2008·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Mohammed F ShamjiLori A Setton
Oct 31, 2009·European Journal of Heart Failure·Maximilian Y EmmertJuerg Gruenenfelder
Jun 7, 2015·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Anna BeattieKumara Ekanayake
Aug 21, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·A C DavaineL Misery
Jan 21, 2006·Journal of Clinical Apheresis·Giancarlo Maria LiumbrunoMaria Laura Sodini
Sep 16, 2008·The Journal of Dermatology·Patcharin JanjumratsangPaisal Roongphibulsopit
May 27, 2006·Arthritis and Rheumatism·Christopher H EvansPaul D Robbins
Nov 15, 2008·International Journal of Dermatology·Martina KucharekovaPamela Poblete-Gutiérrez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.